Definium Therapeutics issues inducement stock options for 45,940 shares to new hires
DFTX•Definium Therapeutics granted inducement stock options covering 45,940 common shares to two newly hired non-executive employees, with grant effective dates of Oct. 13, 2026.
1. Option grant terms
The options vest 25% on the first anniversary, with the remaining 75% vesting in substantially equal monthly installments over the following three years, subject to continued employment.
